Carbon Nanomaterials for Drug Delivery

Abstract:

Carbon Nanotubes (CNTs) and Graphene Have Attracted Tremendous Attention as the Most Promising Carbon Nanomaterials in the 21st Century for a Variety of Applications such as Electronics, Biomedical Engineering, Tissue Engineering, Neuroengineering, Gene Therapy and Biosensor Technology. For the Biomedical Applications, Cnts Have Been Utilized over Existing Drug Delivery Vectors due to their Ability to Cross Cell Membranes Easily and their High Aspect Ratio as Well as High Surface Area, which Provides Multiple Attachment Sites for Drug Targeting. Besides, it Has Also Been Proved that the Functionalization of CNTs May Remarkably Reduce their Cytotoxic Effects and at the Same Time Increase their Biocompatibility. So, the Functionalized CNTs Are Safer than Pristine or Purified CNTs, Thus Offering the Potential Exploitation of Nanotubes for Drug Administration. On the other Hand, More Recently Graphene and its Derivatives Have Been Enormously Investigated in the Biological Applications because of their Biocompatibility, Unique Conjugated Structure, Relatively Low Cost and Availability on both Sides of a Single Sheet for Drug Binding. In Our Study, we Have Covalently Functionalized Multiwalled Carbon Nanotubes (MWCNTs) and Graphene Oxide (GO) with Highly Hydrophilic and Biocompatible Excipients in Order to Increase their Aqueous Solubility and Biocompatibility. Various Excipients Used Were Polyvinyl Alcohol, Pluronic F38, Tween 80 and Maltodextrin. The Poorly Water-Soluble Anticancer Drugs such as, Camptothecin and Ellagic Acid, Were Loaded onto the Functionalized MWCNTs and GO via Non-Covalent Interactions. Furthermore, Drug Loading and Cytotoxic Activity of Drugs Incorporated with the Functionalized MWCNTs and GO as Nanocarriers Were Also Investigated. Drugs Loaded on both Carbon Nanocarriers Exhibited a Higher Cytotoxic Activity than Free Drug. On the other Hand, No Significant Toxicity Was Found even at Higher Concentrations when the Cells Were Incubated with the Functionalized Mwcnts and GO. Therefore, both these Functionalized Carbon Nanomaterials Are Ideal Carriers for Drug Delivery.

• Periodical: Key Engineering Materials (Volume 508)
• Pages: 76-80
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.508.76
• Online since: March 2012
• Authors: Mitali Kakran, Lin Li
• Keywords: Carbon Nanotube (CN), Cell Viability, Cytotoxicity, Drug Delivery, Graphene Oxide, Maltodextrin, Pluronic F38, Poly(vinyl alcohol), Tween 80

References

[1] C.P. Firme III, P.R. Bandaru, Toxicity issues in the application of carbon nanotubes to biological systems, Nanomedicine: NBM 6 (2010) 245–256.

DOI: 10.1016/j.nano.2009.07.003

[2] H. Dumortier, S. Lacotte, G. Pastorin, R. Marega, W. Wu, D. Bonifazi, Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells, Nano Lett. 6 (2006) 1522-1528.

DOI: 10.1021/nl061160x

[3] A. Nimmagadda, K. Thurston, M.U. Nollert, P.S.J. McFetridge, Chemical modification of SWNT alters in vitro Cell-SWNT interactions, Biomed. Mater. Res. 76A (2006) 614-625.

DOI: 10.1002/jbm.a.30577

[4] S. Murugesan, T.J. Park, H. Yang, S. Mousa, R.J. Linhardt, Blood compatible carbon nanotubes − nano-based neoproteoglycans, Langmuir 22 (2006) 3461-3463.

DOI: 10.1021/la0534468

[5] W. Wu, S. Wieckowski, G. Pastorin, M. Benincasa, C. Klumpp, J.P. Briand, Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes, Angew Chem. Int. Ed. 44 (2005) 6358 –6362.

DOI: 10.1002/anie.200501613

[6] Z. Liu, X. Sun, N. Nakayama-Rathford, H. Dai, Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery, ACS Nano 1 (2007) 50-56.

DOI: 10.1021/nn700040t

[7] W. Wu, R. Li, X. Bian, Z. Zhu, D. Ding and X. Li, Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity, ACS Nano 39 (2009) 2740–2750.

DOI: 10.1021/nn9005686

[8] H. Ali-Boucetta, K.T. Al-Jamal, D. McCarthy, M. Prato, A. Bianco, K. Kostarelos, Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics, Chem. Commun. (2008) 459-461.

DOI: 10.1039/b712350g

[9] S. Park, N. Mohanty, J.W. Suk, A. Nagaraja, J.H. An, R.D. Piner, Biocompatible, robust free-standing paper composed of a TWEEN/graphene composite, Adv. Mater. 22 (2010) 1736-1740.

DOI: 10.1002/adma.200903611

[10] Y.B. Zhang, S.F. Ali, E. Dervishi, Y. Xu, Z.R. Li, D. Casciano, Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells, ACS Nano 4 (2010) 3181-3186.

DOI: 10.1021/nn1007176

[11] K.S. Novoselov, A.K. Geim, S.V. Morozov, D. Jiang, Y. Zhang, S.V. Dubonos, I.V. Grigorieva, A.A. Firsov, Electric Field Effect in Atomically Thin Carbon Films, Science, 306(2004) 666-669.

DOI: 10.1126/science.1102896

[12] X. Sun, Z. Liu, K. Welsher, J.T. Robinson, A. Goodwin, S. Zaric, H. Dai, Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res. 1 (2008) 203-212.

DOI: 10.1007/s12274-008-8021-8

[13] Z. Liu, J.T. Robinson, X. Sun, N. Nakayama-Rathford, H. Dai, PEGylated nanographene oxide for delivery of water-insoluble cancer drugs, J. Am. Chem. Soc. 130 (2008) 10876-10877.

DOI: 10.1021/ja803688x

[14] Y. Wang, Z. Li, D. Hu, C.T. Lin, J. Li, Y. Lin, Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells, J. Am. Chem. Soc. 132 (2010) 9274-6.

DOI: 10.1021/ja103169v

[15] C.H. Lu, C.L. Zhu, J. Li, J.J. Liu, X. Chen, H.H. Yang, Using graphene to protect DNA from cleavage during cellular delivery, Chem. Commun. 46 (2010) 3116-8.

DOI: 10.1039/b926893f

[16] X. Yang, X. Zhang, Z. Liu, Y. Ma, Y. Huang, Y. Chen, High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide, J. Phys. Chem. C 112 (2008) 17554–17558.

DOI: 10.1021/jp806751k

[17] Y. Cao, S. Liu, Q. Shen, K. Yan, P.J. Li, J. Xu, D.P. Yu, M.L. Steigerwald, C. Nuckolls, Z.F. Liu, X.F. Guo, High-Performance Photoresponsive Organic Nanotransistors with Single-Layer Graphenes as Two-Dimensional Electrodes, Adv. Funct. Mater. 19 (2009).

DOI: 10.1002/adfm.200900408

[18] H.J. Salavagione, M.A. Gomez, G. Martinez, Polymeric Modification of Graphene through Esterification of Graphite Oxide and Poly(vinyl alcohol), Macromolecules 42 (2009) 6331–6334.

DOI: 10.1021/ma900845w

[19] L. Zhang, J. Xia, Q. Zhao, L. Liu, Z. Zhang, Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs, Small 6 (2010) 537-544.

DOI: 10.1002/smll.200901680

[20] V.K. Rana, M.C. Choi, J.Y. Kong, G.Y. Kim, M.J. Kim, S.H. Kim, S. Mishra, R.P. Singh, C.S. Ha, Synthesis and Drug-Delivery Behavior of Chitosan-Functionalized Graphene Oxide Hybrid Nanosheets, Macromol. Mater. Eng. 296 (2011) 131–140.

DOI: 10.1002/mame.201000307

[21] N.G. Sahoo, H. Bao, Y. Pan, M. Pal, M. Kakran, H.K.F. Cheng, L. Li, L.P. Tan, Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: A comparative study, Chem. Commun. 47 (2011).

DOI: 10.1039/c1cc00075f

[22] M. Kakran, N.G. Sahoo, H. Bao, Y. Pan, L. Li, Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic acid, Curr. Med. Chem. 18 (2011) 4503-4512.

DOI: 10.2174/092986711797287548